Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression

被引:0
|
作者
Lily R. Aleksandrova
Yu Tian Wang
Anthony G. Phillips
机构
[1] Djavad Mowafaghian Centre for Brain Health,Department of Psychiatry
[2] University of British Columbia,Department of Medicine
[3] University of British Columbia,undefined
[4] University of British Columbia,undefined
来源
关键词
Ketamine; Synaptic plasticity; LTP; Hippocampus; HNK; Antidepressant; Memory and cognition; Wistar-Kyoto rat; Model of depression;
D O I
暂无
中图分类号
学科分类号
摘要
Accumulating evidence implicates dysregulation of hippocampal synaptic plasticity in the pathophysiology of depression. However, the effects of ketamine on synaptic plasticity and their contribution to its mechanism of action as an antidepressant, are still unclear. We investigated ketamine’s effects on in vivo dorsal hippocampal (dHPC) synaptic plasticity and their role in mediating aspects of antidepressant activity in the Wistar-Kyoto (WKY) model of depression. dHPC long-term potentiation (LTP) was significantly impaired in WKY rats compared to Wistar controls. Importantly, a single low dose (5 mg/kg, ip) of ketamine or its metabolite, (2R,6R)-HNK, rescued the LTP deficit in WKY rats at 3.5 h but not 30 min following injection, with residual effects at 24 h, indicating a delayed, sustained facilitatory effect on dHPC synaptic plasticity. Consistent with the observed dHPC LTP deficit, WKY rats exhibited impaired hippocampal-dependent long-term spatial memory as measured by the novel object location recognition test (NOLRT), which was effectively restored by pre-treatment with both ketamine or (2R,6R)-HNK. In contrast, in WKYs, which display abnormal stress coping, ketamine, but not (2R,6R)-HNK, had rapid and sustained effects in the forced swim test (FST), a commonly used preclinical screen for antidepressant-like activity. The differential effects of (2R,6R)-HNK observed here reveal a dissociation between drug effects on FST immobility and dHPC synaptic plasticity. Therefore, in the WKY rat model, restoring dHPC LTP was not correlated with ketamine’s effects in FST, but importantly, may have contributed to the reversal of hippocampal-dependent cognitive deficits, which are critical features of clinical depression. Our findings support the theory that ketamine may reverse the stress-induced loss of connectivity in key neural circuits by engaging synaptic plasticity processes to “reset the system”.
引用
收藏
相关论文
共 16 条
  • [11] Corticotropin-Releasing Factor Selectively Enhances the Synaptic Effects of Ketamine Metabolite (2R,6R)-Hydroxynorketamine at the Hippocampal Synapses
    Ajibola, Musa
    Brown, Kyle
    Georgiou, Polymnia
    Gould, Todd
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 202 - 202
  • [12] Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a rat Learned Helplessness Model: Comparison With (R)-Ketamine and (R)-Norketamine
    Shirayama, Yukihiko
    Hashimoto, Kenji
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S542 - S543
  • [13] Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
    Yao, N.
    Skiteva, O.
    Zhang, X.
    Svenningsson, P.
    Chergui, K.
    MOLECULAR PSYCHIATRY, 2018, 23 (10) : 2066 - 2077
  • [14] Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
    N Yao
    O Skiteva
    X Zhang
    P Svenningsson
    K Chergui
    Molecular Psychiatry, 2018, 23 : 2066 - 2077
  • [15] Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepres-sant-Like Activity and Cortical Neurotransmitter Release in Mice?
    Thi Mai Loan Nguyen
    Defaix, Celine
    Mendez-David, Indira
    Thu Ha Pham
    Guilloux, Jean-Philippe
    Etting, Isabelle
    Alvarez, Jean-Claude
    McGowan, Josephine C.
    David, Denis J.
    Denny, Christine A.
    Gardier, Alain
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S349 - S349
  • [16] Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
    Xiong, Zhongwei
    Fujita, Yuko
    Zhang, Kai
    Pu, Yaoyu
    Chang, Lijia
    Ma, Min
    Chen, Jincao
    Hashimoto, Kenji
    BEHAVIOURAL BRAIN RESEARCH, 2019, 368 : 176 - 182